CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS

Uterine fibroids take a second place in the structure of gynecological diseases, after inflammation of genital organs, with a share of 40%. The aim of the study was to investigate cytokine profile and factors of immune dysfunction in patients with uterine fibroids complicated by hemorrhagic syndrome...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	N. F. Khvorostukhina, A. E. Ostrovskaya, D. A. Novichkov, N. N. Stepanova
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2017
Materias:	uterine fibroids cytokines doppler sonography urogenital infections hormone therapy complications Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/3e568cd880f447d6b68788552d6f6a32
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3e568cd880f447d6b68788552d6f6a32
record_format	dspace
spelling	oai:doaj.org-article:3e568cd880f447d6b68788552d6f6a322021-11-18T08:03:46ZCYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS1563-06252313-741X10.15789/1563-0625-2017-6-739-748https://doaj.org/article/3e568cd880f447d6b68788552d6f6a322017-12-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1397https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XUterine fibroids take a second place in the structure of gynecological diseases, after inflammation of genital organs, with a share of 40%. The aim of the study was to investigate cytokine profile and factors of immune dysfunction in patients with uterine fibroids complicated by hemorrhagic syndrome during a course of hormone replacement therapy.А detailed comparative analysis of a survey was performed in 95 women with uterine fibroids. Tumor size did not exceed 12 weeks of pregnancy, mainly with intramural and subserous localization of nodes, having indications for conservative treatment. The main group consisted of 43 patients with uterine fibroids and clinical signs of hemorrhagic syndrome observed in the course of hormone replacement therapy (Buserelindepot 3.75 mg). In a comparison group (n = 52), treatment of fibroids with hormonal therapy was not carried out.A control group comprised healthy women (n = 27). The survey consisted of a comprehensive ultrasound scan with Doppler ultrasound apparatus HITACHI 5500. The immune parameters were evaluated as contents of cytokines (interleukins IL-1β, IL-4, IL-6, IL-2, IFNγ, TNFα) and levels of the Fas-ligand apoptosis marker in blood serum using solid-phase immunoassay technique. For identification of urogenital infection pathogens, methods of diagnostic PCR and ELISA were used.The results of the study were as follows: it is established that emergence of hemorrhagic syndrome on the during hormone therapy for uterine fibroids is associated with activation of latent forms of urogenital infections, being a probable result of potentiating immunosuppressive action of hormonal drugs that promote alterations of immune status, reduction of Th1 and Th2 lymphocyte functions, as well as significant inhibition of apoptosis. In the main group, IL-1β, IL-2, IL-4, IL-6 and IFNγ concentrations were decreased by 1.3 to 1.5 – fold, whereas TNFα and FasL contents were 2 times lower than the levels in control group. In addition, qualitative analysis of uterine hemodynamics has shown that the complications associated with hormone therapy of uterine fibroids are accompanied by a significant increase of the systolic blood flow velocity in the uterine arteries (1.8%), against decrease in diastolic blood flow (2.5 times) and increased resistance index of the vascular wall (1.6 times), as compared with appropriate parameters in healthy women. In conclusion, the received data suggest a need for more detailed examination of women, in order to detect chronic forms of urogenital infections, by means of improving conservative treatment strategies of uterine fibroids, reducing frequency of complications and effectiveness of hormone therapyN. F. KhvorostukhinaA. E. OstrovskayaD. A. NovichkovN. N. StepanovaSPb RAACIarticleuterine fibroidscytokinesdoppler sonographyurogenital infectionshormone therapycomplicationsImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 19, Iss 6, Pp 739-748 (2017)
institution	DOAJ
collection	DOAJ
language	RU
topic	uterine fibroids cytokines doppler sonography urogenital infections hormone therapy complications Immunologic diseases. Allergy RC581-607
spellingShingle	uterine fibroids cytokines doppler sonography urogenital infections hormone therapy complications Immunologic diseases. Allergy RC581-607 N. F. Khvorostukhina A. E. Ostrovskaya D. A. Novichkov N. N. Stepanova CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS
description	Uterine fibroids take a second place in the structure of gynecological diseases, after inflammation of genital organs, with a share of 40%. The aim of the study was to investigate cytokine profile and factors of immune dysfunction in patients with uterine fibroids complicated by hemorrhagic syndrome during a course of hormone replacement therapy.А detailed comparative analysis of a survey was performed in 95 women with uterine fibroids. Tumor size did not exceed 12 weeks of pregnancy, mainly with intramural and subserous localization of nodes, having indications for conservative treatment. The main group consisted of 43 patients with uterine fibroids and clinical signs of hemorrhagic syndrome observed in the course of hormone replacement therapy (Buserelindepot 3.75 mg). In a comparison group (n = 52), treatment of fibroids with hormonal therapy was not carried out.A control group comprised healthy women (n = 27). The survey consisted of a comprehensive ultrasound scan with Doppler ultrasound apparatus HITACHI 5500. The immune parameters were evaluated as contents of cytokines (interleukins IL-1β, IL-4, IL-6, IL-2, IFNγ, TNFα) and levels of the Fas-ligand apoptosis marker in blood serum using solid-phase immunoassay technique. For identification of urogenital infection pathogens, methods of diagnostic PCR and ELISA were used.The results of the study were as follows: it is established that emergence of hemorrhagic syndrome on the during hormone therapy for uterine fibroids is associated with activation of latent forms of urogenital infections, being a probable result of potentiating immunosuppressive action of hormonal drugs that promote alterations of immune status, reduction of Th1 and Th2 lymphocyte functions, as well as significant inhibition of apoptosis. In the main group, IL-1β, IL-2, IL-4, IL-6 and IFNγ concentrations were decreased by 1.3 to 1.5 – fold, whereas TNFα and FasL contents were 2 times lower than the levels in control group. In addition, qualitative analysis of uterine hemodynamics has shown that the complications associated with hormone therapy of uterine fibroids are accompanied by a significant increase of the systolic blood flow velocity in the uterine arteries (1.8%), against decrease in diastolic blood flow (2.5 times) and increased resistance index of the vascular wall (1.6 times), as compared with appropriate parameters in healthy women. In conclusion, the received data suggest a need for more detailed examination of women, in order to detect chronic forms of urogenital infections, by means of improving conservative treatment strategies of uterine fibroids, reducing frequency of complications and effectiveness of hormone therapy
format	article
author	N. F. Khvorostukhina A. E. Ostrovskaya D. A. Novichkov N. N. Stepanova
author_facet	N. F. Khvorostukhina A. E. Ostrovskaya D. A. Novichkov N. N. Stepanova
author_sort	N. F. Khvorostukhina
title	CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS
title_short	CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS
title_full	CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS
title_fullStr	CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS
title_full_unstemmed	CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS
title_sort	cytokine profile in complications of hormone therapy administered for uterine fibroids
publisher	SPb RAACI
publishDate	2017
url	https://doaj.org/article/3e568cd880f447d6b68788552d6f6a32
work_keys_str_mv	AT nfkhvorostukhina cytokineprofileincomplicationsofhormonetherapyadministeredforuterinefibroids AT aeostrovskaya cytokineprofileincomplicationsofhormonetherapyadministeredforuterinefibroids AT danovichkov cytokineprofileincomplicationsofhormonetherapyadministeredforuterinefibroids AT nnstepanova cytokineprofileincomplicationsofhormonetherapyadministeredforuterinefibroids
_version_	1718422411739660288

CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS

Ejemplares similares